-
1
-
-
84898427661
-
Treatment options in patients with metastatic gastric cancer: current status and future perspectives
-
Bilici A. Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World J Gastroenterol. 2014;20:3905-15.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 3905-3915
-
-
Bilici, A.1
-
3
-
-
33745726677
-
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
-
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
-
(2006)
N Engl J Med
, vol.355
, pp. 11-20
-
-
Cunningham, D.1
Allum, W.H.2
Stenning, S.P.3
Thompson, J.N.4
Velde, C.J.5
Nicolson, M.6
-
4
-
-
24944465318
-
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma
-
Ajani JA, Fodor MB, Tjulandin SA, Moiseyenko VM, Chao Y, Cabral Filho S, et al. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. In J Clin Oncol. 2005;23(United States):5660-7.
-
(2005)
In J Clin Oncol
, vol.23
, Issue.UNITED STATES
, pp. 5660-5667
-
-
Ajani, J.A.1
Fodor, M.B.2
Tjulandin, S.A.3
Moiseyenko, V.M.4
Chao, Y.5
Cabral Filho, S.6
-
5
-
-
34548243263
-
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research
-
Roth AD, Fazio N, Stupp R, Falk S, Bernhard J, Saletti P, et al. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. In J Clin Oncol. 2007;25(United States):3217-23.
-
(2007)
In J Clin Oncol
, vol.25
, Issue.UNITED STATES
, pp. 3217-3223
-
-
Roth, A.D.1
Fazio, N.2
Stupp, R.3
Falk, S.4
Bernhard, J.5
Saletti, P.6
-
7
-
-
18244379333
-
Cellular processing of platinum anticancer drugs
-
Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4:307-20.
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 307-320
-
-
Wang, D.1
Lippard, S.J.2
-
8
-
-
84908214095
-
Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
-
Xu J, Yue CF, Zhou WH, Qian YM, Zhang Y, Wang SW, et al. Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis. J Transl Med. 2014;12:200.
-
(2014)
J Transl Med
, vol.12
, pp. 200
-
-
Xu, J.1
Yue, C.F.2
Zhou, W.H.3
Qian, Y.M.4
Zhang, Y.5
Wang, S.W.6
-
10
-
-
84884368877
-
Influence of tumour micro-environment heterogeneity on therapeutic response
-
Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346-54.
-
(2013)
Nature
, vol.501
, pp. 346-354
-
-
Junttila, M.R.1
Sauvage, F.J.2
-
11
-
-
0041528397
-
The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function
-
Monte M, Benetti R, Buscemi G, Sandy P, Del Sal G, Schneider C. The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. J Biol Chem. 2003;278:30356-64.
-
(2003)
J Biol Chem
, vol.278
, pp. 30356-30364
-
-
Monte, M.1
Benetti, R.2
Buscemi, G.3
Sandy, P.4
Sal, G.5
Schneider, C.6
-
12
-
-
0034623393
-
Cell-cycle regulation of the p53-inducible gene B99
-
Collavin L, Monte M, Verardo R, Pfleger C, Schneider C. Cell-cycle regulation of the p53-inducible gene B99. FEBS Lett. 2000;481:57-62.
-
(2000)
FEBS Lett
, vol.481
, pp. 57-62
-
-
Collavin, L.1
Monte, M.2
Verardo, R.3
Pfleger, C.4
Schneider, C.5
-
13
-
-
0032167455
-
A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression
-
Utrera R, Collavin L, Lazarevic D, Delia D, Schneider C. A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. Embo j. 1998;17:5015-25.
-
(1998)
Embo j
, vol.17
, pp. 5015-5025
-
-
Utrera, R.1
Collavin, L.2
Lazarevic, D.3
Delia, D.4
Schneider, C.5
-
14
-
-
1642523688
-
hGTSE-1 expression stimulates cytoplasmic localization of p53
-
Monte M, Benetti R, Collavin L, Marchionni L, Del Sal G, Schneider C. hGTSE-1 expression stimulates cytoplasmic localization of p53. J Biol Chem. 2004;279:11744-52.
-
(2004)
J Biol Chem
, vol.279
, pp. 11744-11752
-
-
Monte, M.1
Benetti, R.2
Collavin, L.3
Marchionni, L.4
Sal, G.5
Schneider, C.6
-
15
-
-
84870917842
-
GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration
-
Scolz M, Widlund PO, Piazza S, Bublik DR, Reber S, Peche LY, et al. GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration. PLoS ONE. 2012;7, e51259.
-
(2012)
PLoS ONE
, vol.7
-
-
Scolz, M.1
Widlund, P.O.2
Piazza, S.3
Bublik, D.R.4
Reber, S.5
Peche, L.Y.6
-
16
-
-
77952344256
-
Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions
-
Hubner NC, Bird AW, Cox J, Splettstoesser B, Bandilla P, Poser I, et al. Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions. J Cell Biol. 2010;189:739-54.
-
(2010)
J Cell Biol
, vol.189
, pp. 739-754
-
-
Hubner, N.C.1
Bird, A.W.2
Cox, J.3
Splettstoesser, B.4
Bandilla, P.5
Poser, I.6
-
17
-
-
84860277040
-
Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles
-
Borner GH, Antrobus R, Hirst J, Bhumbra GS, Kozik P, Jackson LP, et al. Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles. J Cell Biol. 2012;197:141-60.
-
(2012)
J Cell Biol
, vol.197
, pp. 141-160
-
-
Borner, G.H.1
Antrobus, R.2
Hirst, J.3
Bhumbra, G.S.4
Kozik, P.5
Jackson, L.P.6
-
18
-
-
84866722920
-
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples
-
Spanswick VJ, Lowe HL, Newton C, Bingham JP, Bagnobianchi A, Kiakos K, et al. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples. BMC Cancer. 2012;12:436.
-
(2012)
BMC Cancer
, vol.12
, pp. 436
-
-
Spanswick, V.J.1
Lowe, H.L.2
Newton, C.3
Bingham, J.P.4
Bagnobianchi, A.5
Kiakos, K.6
-
19
-
-
84875439460
-
Collections of simultaneously altered genes as biomarkers of cancer cell drug response
-
Masica DL, Karchin R. Collections of simultaneously altered genes as biomarkers of cancer cell drug response. Cancer Res. 2013;73:1699-708.
-
(2013)
Cancer Res
, vol.73
, pp. 1699-1708
-
-
Masica, D.L.1
Karchin, R.2
-
20
-
-
79951986443
-
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients
-
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A, et al. A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS ONE. 2011;6, e16694.
-
(2011)
PLoS ONE
, vol.6
-
-
Kim, H.K.1
Choi, I.J.2
Kim, C.G.3
Kim, H.S.4
Oshima, A.5
Michalowski, A.6
-
21
-
-
84908129534
-
Alteration of gene expression and DNA methylation in drug-resistant gastric cancer
-
Maeda O, Ando T, Ohmiya N, Ishiguro K, Watanabe O, Miyahara R, et al. Alteration of gene expression and DNA methylation in drug-resistant gastric cancer. Oncol Rep. 2014;31:1883-90.
-
(2014)
Oncol Rep
, vol.31
, pp. 1883-1890
-
-
Maeda, O.1
Ando, T.2
Ohmiya, N.3
Ishiguro, K.4
Watanabe, O.5
Miyahara, R.6
-
22
-
-
84867743287
-
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
-
Zeller C, Dai W, Steele NL, Siddiq A, Walley AJ, Wilhelm-Benartzi CS, et al. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling. Oncogene. 2012;31:4567-76.
-
(2012)
Oncogene
, vol.31
, pp. 4567-4576
-
-
Zeller, C.1
Dai, W.2
Steele, N.L.3
Siddiq, A.4
Walley, A.J.5
Wilhelm-Benartzi, C.S.6
-
23
-
-
84863289521
-
Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer
-
Tian T, Zhang E, Fei F, Li X, Guo X, Liu B, et al. Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer. Asian Pac J Cancer Prev. 2011;12:2039-43.
-
(2011)
Asian Pac J Cancer Prev
, vol.12
, pp. 2039-2043
-
-
Tian, T.1
Zhang, E.2
Fei, F.3
Li, X.4
Guo, X.5
Liu, B.6
-
24
-
-
79952356464
-
An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer
-
Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo J, et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 2011;39:1197-207.
-
(2011)
Nucleic Acids Res
, vol.39
, pp. 1197-1207
-
-
Cui, J.1
Chen, Y.2
Chou, W.C.3
Sun, L.4
Chen, L.5
Suo, J.6
-
25
-
-
59149095034
-
Genome-wide expression profile of sporadic gastric cancers with microsatellite instability
-
D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 2009;45:461-9.
-
(2009)
Eur J Cancer
, vol.45
, pp. 461-469
-
-
D'Errico, M.1
Rinaldis, E.2
Blasi, M.F.3
Viti, V.4
Falchetti, M.5
Calcagnile, A.6
-
26
-
-
84930481235
-
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes
-
Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64:706-21.
-
(2012)
Pharmacol Rev
, vol.64
, pp. 706-721
-
-
Shen, D.W.1
Pouliot, L.M.2
Hall, M.D.3
Gottesman, M.M.4
-
27
-
-
68249159896
-
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
-
Li M, Balch C, Montgomery JS, Jeong M, Chung JH, Yan P, et al. Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics. 2009;2:34.
-
(2009)
BMC Med Genomics
, vol.2
, pp. 34
-
-
Li, M.1
Balch, C.2
Montgomery, J.S.3
Jeong, M.4
Chung, J.H.5
Yan, P.6
-
28
-
-
84869044837
-
Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects
-
van Eijk KR, de Jong S, Boks MP, Langeveld T, Colas F, Veldink JH, et al. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics. 2012;13:636.
-
(2012)
BMC Genomics
, vol.13
, pp. 636
-
-
Eijk, K.R.1
Jong, S.2
Boks, M.P.3
Langeveld, T.4
Colas, F.5
Veldink, J.H.6
-
29
-
-
79952703288
-
Cell metabolism: an essential link between cell growth and apoptosis
-
Mason EF, Rathmell JC. Cell metabolism: an essential link between cell growth and apoptosis. Biochim Biophys Acta. 2011;1813:645-54.
-
(2011)
Biochim Biophys Acta
, vol.1813
, pp. 645-654
-
-
Mason, E.F.1
Rathmell, J.C.2
-
30
-
-
84860238289
-
PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21
-
Hoefer J, Schafer G, Klocker H, Erb HH, Mills IG, Hengst L, et al. PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21. Am J Pathol. 2012;180:2097-107.
-
(2012)
Am J Pathol
, vol.180
, pp. 2097-2107
-
-
Hoefer, J.1
Schafer, G.2
Klocker, H.3
Erb, H.H.4
Mills, I.G.5
Hengst, L.6
-
32
-
-
2342459790
-
DNA damage-induced apoptosis
-
Norbury CJ, Zhivotovsky B. DNA damage-induced apoptosis. Oncogene. 2004;23:2797-808.
-
(2004)
Oncogene
, vol.23
, pp. 2797-2808
-
-
Norbury, C.J.1
Zhivotovsky, B.2
-
33
-
-
84888364365
-
Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells
-
Wang L, Gao C, Yao S, Xie B. Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells. Int J Mol Sci. 2013;14:23212-30.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 23212-23230
-
-
Wang, L.1
Gao, C.2
Yao, S.3
Xie, B.4
-
34
-
-
34347385839
-
P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells
-
Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, et al. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin. 2007;28:1057-66.
-
(2007)
Acta Pharmacol Sin
, vol.28
, pp. 1057-1066
-
-
Cui, Q.1
Yu, J.H.2
Wu, J.N.3
Tashiro, S.4
Onodera, S.5
Minami, M.6
-
35
-
-
84884701062
-
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species
-
Hu W, Ge Y, Ojcius DM, Sun D, Dong H, Yang XF, et al. p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species. Cell Microbiol. 2013;15:1642-59.
-
(2013)
Cell Microbiol
, vol.15
, pp. 1642-1659
-
-
Hu, W.1
Ge, Y.2
Ojcius, D.M.3
Sun, D.4
Dong, H.5
Yang, X.F.6
-
36
-
-
77949327543
-
Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment
-
Bublik DR, Scolz M, Triolo G, Monte M, Schneider C. Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment. J Biol Chem. 2010;285:5274-81.
-
(2010)
J Biol Chem
, vol.285
, pp. 5274-5281
-
-
Bublik, D.R.1
Scolz, M.2
Triolo, G.3
Monte, M.4
Schneider, C.5
-
37
-
-
67649424560
-
p21 in cancer: intricate networks and multiple activities
-
Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400-14.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 400-414
-
-
Abbas, T.1
Dutta, A.2
|